• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login

    Investing News NetworkYour trusted source for investing success

    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Australia Cannabis Market
    Australia Cannabis News
    Australia Cannabis Stocks
    • Australia Cannabis Market
    • Australia Cannabis News
    • Australia Cannabis Stocks

    Medlab Posts Quarterly Results, Gives Trial Update

    Bryan Mc Govern
    Oct. 30, 2019 03:05PM PST
    Australia Cannabis Investing

    Medlab ran through the highlights of its most recent earnings period as the firm issued its report for the most recent quarterly period.

    Medlab (ASX:MDC) ran through the highlights of its most recent earnings period as the firm issued its report for the most recent quarterly period.

    As quoted in the press release:

    The key highlights for the period have been:

    • Recruitment in Medlab’s Phase 2 trial at Royal North Shore Hospital is completed and results expected by Christmas.
    • Collections of AU$2.401m, an increase of approx. 96 percent over the corresponding period last year.
    • R&D Tax Incentive FY 2019 of AU$2.1m was received in October.
    • Agreement executed to expand nutraceuticals to USA
    • First export order of Medlab’s newest cannabinoid (NanoCBD) of 1,500 units to Hong Kong received and deposit paid.

    The current quarter and first quarter next year are expected to be exciting for the company with the release of Phase 2 trial data and preparation for Phase 3 trial in the US and Australia.

    We expect to deliver significant news on progress on across our businesses and exciting opportunities for our customers, our staff and our shareholders.

    Click here to read the full press release.

    australiaasx:mdcmedlab
    The Conversation (0)
    Go Deeper
    AI Powered
    Person touching a cannabis plant; Australia map in flag colours.

    ASX Cannabis Stocks: 10 Biggest Companies

    Row of test tubes and pipette with chemical droplet chemical coming from it.

    Top 5 Small-cap Biotech Stocks of 2025

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Australia Cannabis Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×